Corporate Overview
At Personalis, the fight against cancer is personal.
At Personalis, our mission is to transform the active management of cancer through breakthrough personalized testing. Our advanced genomic tests detect ultra-low traces of minimal residual disease (MRD) and recurrence, uncover deeper insights for therapy selection, and power the design of individualized neoantigen therapies.
Personalizing precision oncology
Personalis was founded in 2011 by a team of internationally-renowned next-generation sequencing (NGS) thought-leaders from Stanford University. We’re committed to building a world where personalized testing provides greater confidence and exceptional outcomes for cancer patients.
Our headquarters – housing our CLIA-certified, CAP-accredited laboratory – recently relocated to a state-of-the-art facility in Fremont, CA.